Compendium of Cancer Genome Aberrations

HAEM5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older editNewer edit →
VisualWikitext
No edit summary
No edit summary
Line 1: Line 1:
Welcome!
BWelcome!


'''A new version of the Heme/Lymphoid book (5th edition) is in beta form on the WHO website with publication of a final form anticipated in 2024; we're aligning the related CCGA content to the new structure.'''
'''A new version of the Heme/Lymphoid book (5th edition) is in beta form on the WHO website with publication of a final form anticipated in 2024; we're aligning the related CCGA content to the new structure.'''
Line 1,384: Line 1,384:
|01/24/2022. Emailed 5/1/2025, no response
|01/24/2022. Emailed 5/1/2025, no response
|Date completed by author: 01/24/2022
|Date completed by author: 01/24/2022
|-
!Disease (5th Edition)
!Page Type
!<span style="color:#0070C0">Author (5th Edition) (Note: please indicate trainees in parentheses)
!Date Assigned to Author (5th Edition)
!Target Completion Date (5th Edition)
!Content Status (5th Edition)(Pending or Complete)
!Date Completed by Author (5th Edition)
!Associate Editor
!Date of Last Editor Review (5th Edition)
!Notes (5th Edition)
!Correlated Prior Disease Name (4th Edition)
!Correlated Prior Author (4th Edition)
!Prior Content Status (4th Edition)(Pending or Complete)
!Prior Date of Last Editor Review (4th Edition)
!Prior Notes (4th Edition)
|-
|-
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma|B-lymphoblastic leukaemia/lymphoma]]
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma|B-lymphoblastic leukaemia/lymphoma]]
|Disease
|Disease
|
|Karin Miller, MD
|
|10/9/2025
|
|
|
|
Line 1,403: Line 1,419:
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy|B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy]]
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy|B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy]]
|Disease
|Disease
|Miguel Gonzalez Mancera
|Miguel Gonzalez Mancera, MD
|
|
|
|
Line 1,419: Line 1,435:
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma with hypodiploidy|B-lymphoblastic leukaemia/lymphoma with hypodiploidy]]
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma with hypodiploidy|B-lymphoblastic leukaemia/lymphoma with hypodiploidy]]
|Disease
|Disease
|Miguel Gonzalez Mancera
|Miguel Gonzalez Mancera, MD
|
|
|
|
Line 1,435: Line 1,451:
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma with iAMP21|B-lymphoblastic leukaemia/lymphoma with iAMP21]]
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma with iAMP21|B-lymphoblastic leukaemia/lymphoma with iAMP21]]
|Disease
|Disease
|Holli Drendel
|Holli Drendel, PhD
|
|
|
|
Line 1,449: Line 1,465:
|
|
|-
|-
!Disease (5th Edition)
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion]]
!Page Type
|Disease
!<span style="color:#0070C0">Author (5th Edition) (Note: please indicate trainees in parentheses)
!Date Assigned to Author (5th Edition)
!Target Completion Date (5th Edition)
!Content Status (5th Edition)(Pending or Complete)
!Date Completed by Author (5th Edition)
!Associate Editor
!Date of Last Editor Review (5th Edition)
!Notes (5th Edition)
!Correlated Prior Disease Name (4th Edition)
!Correlated Prior Author (4th Edition)
!Prior Content Status (4th Edition)(Pending or Complete)
!Prior Date of Last Editor Review (4th Edition)
!Prior Notes (4th Edition)
|-
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion]]
|Disease
|Karin Miller, MD
|Karin Miller, MD
|10/9/2025
|10/9/2025
Line 1,485: Line 1,485:
|Mark G. Evans, MD; Kilannin Krysiak, PhD
|Mark G. Evans, MD; Kilannin Krysiak, PhD
|10/1/2025
|10/1/2025
|
|11/17/2025
|Pending
|Pending
|
|
Line 1,501: Line 1,501:
|Gokce A. Toruner, MD, PhD
|Gokce A. Toruner, MD, PhD
|10/9/2025
|10/9/2025
|
|11/5/2025
|
|Pending
|
|
|SK
|SK
Line 1,517: Line 1,517:
|Gokce A. Toruner, MD, PhD
|Gokce A. Toruner, MD, PhD
|10/8/2025
|10/8/2025
|
|12/1/2025
|
|Pending
|
|
|SK
|SK
Line 1,531: Line 1,531:
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features|B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features]]
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features|B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features]]
|Disease
|Disease
|Lei Zhang;
|Lei Zhang, PhD
Michelle Fan (trainee)
Michelle Fan (trainee)
|8/8/2024
|10/10/2025
|
|12/22/2025
|Pending
|Pending
|
|
Line 1,549: Line 1,549:
|Disease
|Disease
|Miguel Gonzalez Mancera, MD
|Miguel Gonzalez Mancera, MD
|10/1/2025
|
|
|
|Pending
|
|
|
|SK
|SK
Line 1,565: Line 1,565:
|Disease
|Disease
|Miguel Gonzalez Mancera, MD
|Miguel Gonzalez Mancera, MD
|10/1/2025
|
|
|
|Pending
|
|
|
|SK
|SK
Line 1,580: Line 1,580:
|[[HAEM5:B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion|B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion]]
|[[HAEM5:B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion|B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion]]
|Disease
|Disease
|Aiko Otsubo
|Aiko Otsubo, PhD
|6/25/2024
|10/10/2025
|
|11/24/2025
|Pending
|Pending
|
|
Line 1,596: Line 1,596:
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations|B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations]]
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations|B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations]]
|Disease
|Disease
|Lei Zhang;
|Lei Zhang, PhD
Michelle Fan (trainee)
|10/10/2025
|8/8/2024
|
|
|Pending
|Pending
Line 1,612: Line 1,611:
|-
|-
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma, NOS|B-lymphoblastic leukaemia/lymphoma, NOS]]
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma, NOS|B-lymphoblastic leukaemia/lymphoma, NOS]]
|Disease
|Disease (See [https://ccga.io/index.php/HAEM5:B-lymphoblastic_leukaemia/lymphoma B-lymphoblastic leukaemia/lymphoma])
|Karin Miller, MD
|
|10/9/2025
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
|
----
|
|
----
|
|
|SK
----
|
|
----
|
|
|NEW (No Prior)
----
|NEW (No Prior)
|NEW (No Prior)
|NEW (No Prior)
|NEW (No Prior)
|-
|-
!Disease (5th Edition)
!Disease (5th Edition)
Retrieved from "https://test.ccga.io/index.php/HAEM5:Volunteer_Assignments_and_Opportunities"